Knowing it's a little too broad now, I think we also heard that the consent was too narrow, too restrictive.
I don't think I heard from you, but I've heard from other witnesses that they're also concerned that there is an issue around conflicting or overlapping regulations. The do-not-call list, for example, has different consent provisions. PIPEDA has different consent provisions. Would you care to comment on the differences?